Status:
NOT_YET_RECRUITING
MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy
Lead Sponsor:
Fujian Cancer Hospital
Conditions:
Cervical Cancer
Radiotherapy
Eligibility:
FEMALE
20-85 years
Brief Summary
This study aims to validate the value of tumor involvement features based on MRI in cervical cancer, facilitate the development of a more appropriate model for risk stratification, and help patients w...
Detailed Description
Even with the development of advanced technology, the prognosis for CC patients who received radiotherapy is still an intractable problem. Almost 40% suffered disease recurrence among locally advanced...
Eligibility Criteria
Inclusion
- (1) pathologically confirmed CC, (2) initially treated in our center
Exclusion
- (1) lack of pre-treatment MRI, (2) prior anti-tumor treatment, (3) pelvic surgery history, (4) incomplete therapy, (5) loss of follow-up
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06197126
Start Date
January 1 2024
End Date
December 31 2028
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Cancer Hospital
Fuzhou, Fujian, China, 350014